Skip to main content

Botulinum Toxin Treatment in Ophthalmology and Ophthalmic Surgery

  • Chapter
  • First Online:
Botulinum Toxin Treatment in Surgery, Dentistry, and Veterinary Medicine
  • 420 Accesses

Abstract

This chapter explores the clinical use of botulinum toxin therapy in ophthalmology and ophthalmic surgery. Ophthalmic conditions that can benefit from botulinum toxin therapy include blepharospasm, strabismus, nystagmus, lacrimal hypersecretion syndromes, eyelid retraction and spastic entropion among others. Since its first use in blepharospasm in 1983, toxin therapy has become the treatment of choice for blepharospasm with successful outcomes. This chapter also explores the techniques of injection, application and complications of toxin therapy in these conditions. Whilst generally considered safe, some of the complications of ophthalmic toxin therapy include ptosis, diplopia, dry eyes and epiphora.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Bibliography

  1. Scott AB. Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology. 1980;87(10):1044–9. https://doi.org/10.1016/s0161-6420(80)35127-0.

    Article  CAS  PubMed  Google Scholar 

  2. Taylor JD, Kraft SP, Kazdan MS, Flanders M, Cadera W, Orton RB. Treatment of blepharospasm and hemifacial spasm with botulinum A toxin: a Canadian multicentre study. Can J Ophthalmol. 1991;26(3):133–8. http://www.ncbi.nlm.nih.gov/pubmed/2054723. Accessed December 1, 2019

    CAS  PubMed  Google Scholar 

  3. Scott AB, Stubbs HA, Kennedy RA. Botulinum a toxin injection as a treatment for blepharospasm. Arch Ophthalmol. 1985;103(3):347–50. https://doi.org/10.1001/archopht.1985.01050030043017.

    Article  CAS  PubMed  Google Scholar 

  4. Tsoy EA, Buckley EG, Dutton JJ. Treatment of Blepharospasm with botulinum toxin. Am J Ophthalmol. 1985;99(2):176–9. https://doi.org/10.1016/0002-9394(85)90228-4.

    Article  CAS  PubMed  Google Scholar 

  5. Dutton JJ, Buckley EG. Long-term results and complications of botulinum A toxin in the treatment of blepharospasm. Ophthalmology. 1988;95(11):1529–34. https://doi.org/10.1016/s0161-6420(88)32977-5.

    Article  CAS  PubMed  Google Scholar 

  6. Calace P, Cortese G, Piscopo R, et al. Treatment of Blepharospasm with botulinum neurotoxin type A: long-term results. Eur J Ophthalmol. 2003;13(4):331–6. https://doi.org/10.1177/112067210301300401.

    Article  CAS  PubMed  Google Scholar 

  7. Osako M, Keltner JL. Botulinum A toxin (Oculinum) in ophthalmology. Surv Ophthalmol. 1991;36(1):28–46. https://doi.org/10.1016/0039-6257(91)90207-v.

    Article  CAS  PubMed  Google Scholar 

  8. Kraft SP, Lang AE. Botulinum toxin injections in the treatment of blepharospasm, hemifacial spasm, and eyelid fasciculations. Can J Neurol Sci. 1988;15(3):276–80. https://doi.org/10.1017/s0317167100027748.

    Article  CAS  PubMed  Google Scholar 

  9. Mauriello JA Jr. Blepharospasm, Meige syndrome, and hemifacial spasm: treatment with botulinum toxin. Neurology. 1985;35(0028-3878 (Print)):1499–500.

    Article  Google Scholar 

  10. Jitpimolmard S, Tiamkao S, Laopaiboon M. Long term results of botulinum toxin type A (Dysport) in the treatment of hemifacial spasm: a report of 175 cases. J Neurol Neurosurg Psychiatry. 1998;64(6):751–7. https://doi.org/10.1136/jnnp.64.6.751.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Grandas F, Elston J, Quinn N, Marsden CD. Blepharospasm: a review of 264 patients. J Neurol Neurosurg Psychiatry. 1988;51(6):767–72. https://doi.org/10.1136/jnnp.51.6.767.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Cillino S, Raimondi G, Guépratte N, et al. Long-term efficacy of botulinum toxin A for treatment of blepharospasm, hemifacial spasm, and spastic entropion: a multicentre study using two drug-dose escalation indexes. Eye. 2010;24(4):600–7. https://doi.org/10.1038/eye.2009.192.

    Article  CAS  PubMed  Google Scholar 

  13. Elston JS. Long-term results of treatment of idiopathic blepharospasm with botulinum toxin injections. Br J Ophthalmol. 1987;71(9):664–8. https://doi.org/10.1136/bjo.71.9.664.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Grandas F, Elston J, Quinn JN, Marsden CD, Quinn N. Blepharospasm: a review of 264 patients. J Neurol Neurosurg Psychiatry. 1988;51:767–72. https://doi.org/10.1136/jnnp.51.6.767.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Engstrom PF, Arnoult JB, Mazow ML, et al. Effectiveness of botulinum toxin therapy for essential Blepharospasm. Ophthalmology. 1987;94(8):971–5. https://doi.org/10.1016/S0161-6420(87)33338-X.

    Article  CAS  PubMed  Google Scholar 

  16. Frueh BR, Musch DC. Treatment of facial spasm with botulinum toxin. An interim report. Ophthalmology. 1986;93(7):917–23. https://doi.org/10.1016/s0161-6420(86)33641-8.

    Article  CAS  PubMed  Google Scholar 

  17. Dutton JJ. Botulinum-A toxin in the treatment of craniocervical muscle spasms: short- and long-term, local and systemic effects. Surv Ophthalmol. 1996;41(1):51–65. https://doi.org/10.1016/s0039-6257(97)81995-9.

    Article  CAS  PubMed  Google Scholar 

  18. Dutton JJ, Fowler AM. Botulinum toxin in ophthalmology. Surv Ophthalmol. 2007;52(1):13–31. https://doi.org/10.1016/j.survophthal.2006.10.003.

    Article  PubMed  Google Scholar 

  19. Carruthers J, Stubbs HA. Botulinum toxin for benign essential blepharospasm, hemifacial spasm and age-related lower eyelid entropion. Can J Neurol Sci. 1987;14(1):42–5. https://doi.org/10.1017/s0317167100026159.

    Article  CAS  PubMed  Google Scholar 

  20. Owens PL, Strominger MB, Rubin PA, Veronneau-Troutman S. Large-angle exotropia corrected by intraoperative botulinum toxin a and monocular recession resection surgery. J AAPOS Off Publ Am Assoc Pediatr Ophthalmol Strabismus. 1998;2(3):144–6. https://doi.org/10.1016/s1091-8531(98)90004-0.

    Article  CAS  Google Scholar 

  21. Khan AO. Two horizontal rectus eye muscle surgery combined with botulinum toxin for the treatment of very large angle esotropia. A pilot study. Binocul Vis Strabismus Q. 2005;20(1):15–20. http://www.ncbi.nlm.nih.gov/pubmed/15828866. Accessed December 4, 2019

    PubMed  Google Scholar 

  22. Jain S, Anand SS, Jones A. Intraoperative botulinum toxin in large angle strabismus. J Am Assoc Pediatr Ophthalmol Strabismus. 2015;19(4):e12. https://doi.org/10.1016/j.jaapos.2015.07.007.

    Article  Google Scholar 

  23. McNeer KW, Tucker MG, Guerry CH, Spencer RF. Incidence of stereopsis after treatment of infantile esotropia with botulinum toxin A. J Pediatr Ophthalmol Strabismus. 2003;40(5):288–92. http://www.ncbi.nlm.nih.gov/pubmed/14560837. Accessed December 4, 2019

    Article  Google Scholar 

  24. de Oliveira FC, de Oliveira GC, Cariello AJ, Felberg S, Osaki MH. Botulinum toxin type A influence on the lacrimal function of patients with facial dystonia. Arq Bras Oftalmol. 2010;73(5):405–8. https://doi.org/10.1590/s0004-27492010000500003.

    Article  PubMed  Google Scholar 

  25. Sahlin S, Chen E, Kaugesaar T, Almqvist H, Kjellberg K, Lennerstrand G. Effect of eyelid botulinum toxin injection on lacrimal drainage. Am J Ophthalmol. 2000;129(4):481–6. https://doi.org/10.1016/s0002-9394(99)00408-0.

    Article  CAS  PubMed  Google Scholar 

  26. Carruthers J. The treatment of congenital nystagmus with Botox. J Pediatr Ophthalmol Strabismus. 1995;32(5):306–8. https://doi.org/10.3928/0191-3913-19950901-09.

    Article  CAS  PubMed  Google Scholar 

  27. Leigh RJ, Tomsak RL, Grant MP, et al. Effectiveness of botulinum toxin administered to abolish acquired nystagmus. Ann Neurol. 1992;32(5):633–42. https://doi.org/10.1002/ana.410320506.

    Article  CAS  PubMed  Google Scholar 

  28. Repka MX, Savino PJ, Reinecke RD. Treatment of acquired nystagmus with botulinum neurotoxin A. Arch Ophthalmol. 1994;112(10):1320–4. https://doi.org/10.1001/archopht.1994.01090220070025.

    Article  CAS  PubMed  Google Scholar 

  29. Corridan P, Nightingale S, Mashoudi N, Williams AC. Acute angle-closure glaucoma following botulinum toxin injection for blepharospasm. Br J Ophthalmol. 1990;74(5):309–10. https://doi.org/10.1136/bjo.74.5.309.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Zheng L, Azar D. Angle-closure glaucoma following periorbital botulinum toxin injection. Clin Exp Ophthalmol. 2014;42(7):690–3. https://doi.org/10.1111/ceo.12293.

    Article  PubMed  Google Scholar 

  31. Liu M, Lee HC, Hertle RW, Ho AC. Retinal detachment from inadvertent intraocular injection of botulinum toxin A. Am J Ophthalmol. 2004;137(1):201–2. https://doi.org/10.1016/s0002-9394(03)00837-7.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Keya Jafari .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Jafari, K., Jain, S. (2020). Botulinum Toxin Treatment in Ophthalmology and Ophthalmic Surgery. In: Jabbari, B. (eds) Botulinum Toxin Treatment in Surgery, Dentistry, and Veterinary Medicine. Springer, Cham. https://doi.org/10.1007/978-3-030-50691-9_13

Download citation

Publish with us

Policies and ethics